Bolt Biotherapeutics Files Definitive Proxy Statement
Ticker: BOLT · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1641281
| Field | Detail |
|---|---|
| Company | Bolt Biotherapeutics, Inc. (BOLT) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing, governance
TL;DR
Bolt Bio filed its proxy statement, shareholders vote soon.
AI Summary
Bolt Biotherapeutics, Inc. filed its definitive proxy statement on April 25, 2025, for the fiscal year ending December 31, 2024. The filing pertains to the company's annual meeting and is a standard DEF 14A filing, indicating it's a proxy statement for shareholders.
Why It Matters
This filing provides shareholders with essential information regarding the company's governance, executive compensation, and proposals to be voted on at the upcoming annual meeting, impacting their investment decisions.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new material financial information or strategic changes.
Key Players & Entities
- Bolt Biotherapeutics, Inc. (company) — Registrant
- April 25, 2025 (date) — Filing Date
- December 31, 2024 (date) — Fiscal Year End
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxy votes from shareholders for their annual or special meetings, providing details on matters to be voted upon.
When was Bolt Biotherapeutics, Inc. incorporated?
Bolt Biotherapeutics, Inc. was incorporated in Delaware (DE).
What is the Standard Industrial Classification (SIC) code for Bolt Biotherapeutics, Inc.?
The SIC code for Bolt Biotherapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of Bolt Biotherapeutics, Inc.?
The business address of Bolt Biotherapeutics, Inc. is 900 Chesapeake Drive, Redwood City, CA 94063.
Has Bolt Biotherapeutics, Inc. changed its name previously?
Yes, the company was formerly known as Bolt Therapeutics, Inc., with a name change date of May 4, 2015.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Bolt Biotherapeutics, Inc. (BOLT).